Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Onconetix, Inc. issued warrants to purchase 2,025,223 shares of Common Stock of warrant to institutional investors for aggregate purchase price of approximately $6.25 million.
- Security
- warrant
- Shares
- warrants to purchase 2,025,223 shares of Common Stock
- Purchaser
- institutional investors
- Consideration
- aggregate purchase price of approximately $6.25 million
Exact text from the filing
On October 1, 2025, Onconetix, Inc., a Delaware corporation (the “ Company ”), entered into, and sold to institutional investor(s) (collectively, the “ PIPE Investors ”), pursuant to a securities purchase agreement (the “ Securities Purchase Agreement ”) an aggregate of 7,813 shares of Series E convertible preferred stock, par value $0.00001 per share (“ Series E Preferred Stock ”), which are convertible into common stock of the Company, $0.00001 par value per share (the “ Common Stock ”) and warrants to purchase 2,025,223 shares of Common Stock (the “ Warrants ” and, together with the Series E Preferred Stock, the “ PIPE Securities ”), for an aggregate purchase price of approximately $6.25 million.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Onconetix, Inc. issued 7,813 shares of Series E convertible preferred stock of preferred stock to institutional investors for aggregate purchase price of approximately $6.25 million.
- Security
- preferred stock
- Shares
- 7,813 shares of Series E convertible preferred stock
- Purchaser
- institutional investors
- Consideration
- aggregate purchase price of approximately $6.25 million
Exact text from the filing
On October 1, 2025, Onconetix, Inc., a Delaware corporation (the “ Company ”), entered into, and sold to institutional investor(s) (collectively, the “ PIPE Investors ”), pursuant to a securities purchase agreement (the “ Securities Purchase Agreement ”) an aggregate of 7,813 shares of Series E convertible preferred stock, par value $0.00001 per share (“ Series E Preferred Stock ”), which are convertible into common stock of the Company, $0.00001 par value per share (the “ Common Stock ”) and warrants to purchase 2,025,223 shares of Common Stock (the “ Warrants ” and, together with the Series E Preferred Stock, the “ PIPE Securities ”), for an aggregate purchase price of approximately $6.25 million.
View on SEC.gov